MUSTAFA QURESHI: Open Payments
NPI 1578011656 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 8 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Noven Therapeutics, LLC | 1 | $19 |
Products named: INGREZZA, TRINTELLIX, UZEDY, FANAPT, Xelstrym.
Industry payments across IN — which companies pay providers there.
